MedTrace Logo

Zirconia-Reinforced Glass Ionomer Versus Injectable Giomer in Class V Restorations

NCT07731308 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-07-28

No results posted yet for this study

Summary

This randomized controlled clinical trial aims to compare the clinical performance of zirconia-reinforced glass ionomer and injectable giomer restorations in Class V carious lesions among controlled type II diabetic against non-diabetics. One hundred Class V restorations will be allocated equally into four parallel groups according to restorative material and diabetic status. Clinical performance will be evaluated at baseline, 6, 12, and 18 months using the modified United States Public Health Service (USPHS) criteria. The primary outcome is restoration retention, while secondary outcomes include marginal adaptation, marginal discoloration, secondary caries, and postoperative sensitivity.

Conditions

  • Class V Dental Caries, Type 2 Diabetes Mellitus
  • Giomer Technology; Injectable Resin Composite; Zirconia-Modified Glass Ionomer

Interventions

OTHER

Zirconomer

Zirconia-reinforced glass ionomer restorative material (SHOFU)

OTHER

Beautifil Flow Plus X

Injectable giomer restorative material incorporating S-PRG technology (SHOFU)

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2027-01-31
Primary Completion
2028-06-30
Completion
2029-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07731308 on ClinicalTrials.gov